XML 62 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 29, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net income $ 14,441 $ 31,894
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 31,046 33,185
Share-based compensation 4,539 5,022
Impairment of long-lived assets 4,587 1,486
Deferred income tax 748 842
Non-cash rental expense, net 6,218 7,818
Change in operating lease liabilities (10,611) (10,496)
Net (recognition) receipt of deferred vendor incentives (2,305) 8,033
System optimization gains, net (323) (12)
Distributions received from joint ventures, net of equity in earnings 180 415
Long-term debt-related activities, net 1,556 1,823
Changes in operating assets and liabilities and other, net (69,445) (17,989)
Net cash (used in) provided by operating activities (19,369) 62,021
Cash flows from investing activities:    
Capital expenditures (12,629) (11,215)
Acquisitions 0 (5,052)
Dispositions 195 0
Proceeds from sale of investments 0 130
Notes receivable, net 313 248
Net cash used in investing activities (12,121) (15,889)
Cash flows from financing activities:    
Proceeds from long-term debt 153,315 0
Repayments of long-term debt (14,334) (5,813)
Repayments of finance lease liabilities (1,967) (1,881)
Repurchases of common stock (45,137) (30,929)
Dividends (26,793) (23,069)
Proceeds from stock option exercises 1,722 5,196
Payments related to tax withholding for share-based compensation (3,402) (6,055)
Net cash provided by (used in) financing activities 63,404 (62,551)
Net cash provided by (used in) operations before effect of exchange rate changes on cash 31,914 (16,419)
Effect of exchange rate changes on cash (5,086) 1,884
Net increase (decrease) in cash, cash equivalents and restricted cash 26,828 (14,535)
Cash, cash equivalents and restricted cash at beginning of period 358,707 486,512
Cash, cash equivalents and restricted cash at end of period 385,535 471,977
Supplemental non-cash investing and financing activities:    
Capital expenditures included in accounts payable 9,579 5,125
Finance leases 9,274 13,810
Reconciliation of cash, cash equivalents and restricted cash at end of period:    
Total cash, cash equivalents and restricted cash $ 358,707 $ 471,977